Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 28Other 1

Conditions

Sexual Dysfunctions, Psychological 1Prostatic Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metabolic Syndrome 1Metabolic Diseases 1Eunuchism 1Diabetes Mellitus 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Exercise 9exemestane 4Psychiatric Rehabilitation 4Tamoxifen 3Methods 3Metformin 3Letrozole 3Early Intervention, Educational 3Diet Therapy 3Bupropion 3Bariatric Surgery 3Anastrozole 3Vitamin D 2Therapeutics 2Sugars 2Specimen Handling 2Naltrexone 2Mammography 2Diet, Mediterranean 2Counseling 2Cognitive Behavioral Therapy 2Cholecalciferol 2Blood Specimen Collection 2rosiglitazone-metformin combination 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Yoga 1Walking 1Tirzepatide 1Testosterone Propionate 1Testosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Gonadotropin-Releasing Hormone × Other × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡